DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q2 2023 13F-HR Holdings
Net value change ($000)
+198,526
(4.4%)
New positions
18
Sold out positions
17
Turnover %
16.5%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NUVL | 321,455 | 61.6% |
| ADY | 54,955 | 50.4% |
| Merus N.V. | 36,031 | 82.3% |
| ACH | 34,074 | 60.6% |
| IDYA | 29,373 | 122.7% |
| RVMD | 28,881 | 160.7% |
| APLS | 28,541 | NEW |
| GH | 26,633 | 145.9% |
| CABA | 26,372 | 686.9% |
| CNC | 23,039 | 33.9% |
Top Reduces (Value $000, Stocks/ETFs)
| NBIX | -62,524 | -35.4% |
| CPRX | -61,588 | -35.9% |
| MIRM | -48,817 | -100.0% |
| Intra-Cellular Therapies, Inc. | -39,746 | -100.0% |
| IVERIC bio, Inc. | -36,606 | -100.0% |
| AMLX | -35,567 | -61.1% |
| Silk Road Medical Inc | -30,738 | -45.5% |
| EOLS | -30,194 | -100.0% |
| BELLUS Health Inc. | -25,783 | -100.0% |
| KRYS | -24,975 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|